Keywords: Novartis, UK, NICE, Lucentis, Diabetic macular degeneration, Fluvirin, US shipments, Flu vaccine

UK’s NICE unable to recommend Novartis Lucentis for diabetic macular edema; Fluvirin shipments begin in USA

Article | 18 July 2011

Print This

The UK’s drug watchdog the National Institute for Health and Clinical Excellence (NICE) has issued a final draft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in